Nobel Prize in chemistry winners professor Frances Arnold and Sir Gregory Winter argued that biotech crops, such as drought and disease-resistant ones, could make food production more environmentally sustainable and that regulations should be loosened.
Maersk sees the use of carbon-neutral fuels such as biofuels as the only possible way to achieve net zero carbon dioxide emissions by 2050. "The next five to 10 years are going to be crucial. We will invest significant resources for innovation and fleet technology to improve the technical and financial viability of decarbonized solutions," says Maersk's Soren Toft.
An offering of 2.5 million shares of common stock has been priced by Inspire Medical Systems at $40 per share. The offering, which will close Tuesday, includes an over-allotment option for the underwriters to buy 375,000 more shares.
An oversubscribed rights offering has brought in $45 million for Pulse Biosciences. The funding will be used to help commercialize the company's CellFX Nano-Pulse Stimulation platform, beginning with use in aesthetic dermatology.
An underwritten follow-on common stock offering has been priced by OrthoPediatrics at $27 per share. Proceeds from the public offering, which includes 1.5 million shares, will be used as working capital, for research and development and for sales and marketing program expansion, among other things.
A report from Moody's Investors Service shows a positive outlook in 2019 for the US medical device industry, predicting a 4.5% to 5.5% increase in EBITDA growth. Product innovation will also drive mid-single-digit revenue growth for most firms and product categories, and operating margins will benefit from acquisition synergies, the report says.
An Insight Partners report forecasts the worldwide market for sports medicine devices will exceed $10.5 million by 2025, with the fastest growth expected from the knee devices segment. Stryker, Smith & Nephew, DJO Global, Zimmer Biomet, DePuy Synthes, RTI Surgical and Wright Medical Group are among the key market players.
The NIH's National Institute of Arthritis and Musculoskeletal and Skin Diseases division has awarded Bruin Biometrics a Small Business Innovation Research Phase II grant worth $1.4 million. The grant is expected to support the advancement of detection capabilities, clinical evaluation and design of the company's novel acoustic emission device for orthopedics, OrthoSonos.
The FDA has granted Contego Medical 510(k) clearance for its Vanguard IEP peripheral balloon, which comes with an embolic protection function for patients who face a high embolization risk during peripheral angioplasty.
Meril Life Sciences' MyVal transcatheter aortic heart valve replacement has been launched in India. The artificial aortic valve, designed and manufactured in the country, will be available for high-risk patients and those unwilling to undergo open heart valve replacement surgery.